Skip to main content

ALXO- Alx Oncology Holdings Inc

Alx Oncology Holdings Inc (ALXO) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. ALXO is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

RoleInsiderSharesValue30d
CEO305.9K$468.1K-
CFO303.0K$463.6K-
Dir300.0K$459.0K-
VP192.0K$293.8K-
10%40.4K$61.8K-

Activity

Buys and sells only

Transactions

10 filings · page 3
DateInsiderRoleTypeSharesPriceValueChg%3M12MSEC
Jul 1, 2024Randolph Sophia88Chief Medical OfficerSell3,273$5.82$19,044.93-1.0%-69.6%-92.8%
Jul 1, 2024Pons Jaume89President &CSOSell10,758$5.82$62,598.65-1.8%-69.6%-92.8%
Jun 13, 2024Garcia Peter S81Chief Financial OfficerBuy12,000$8.53$102,338.40+10.9%-74.2%-93.9%
Jun 4, 2024Pons Jaume89President &CSOSale+OE20,000$8.43$168,652.00-3.2%-74.4%-93.6%
May 13, 2024Randolph Sophia88Chief Medical OfficerSell12,000$15.94$191,338.70-1.8%-83.9%-96.9%
May 6, 2024Pons Jaume89President &CSOSale+OE20,000$15.92$318,334.00-3.2%-82.7%-96.8%
Apr 16, 2024Pons Jaume89President &CSOSale+OE50,000$14.20$710,195.00-7.6%-44.8%-96.1%
Apr 4, 2024Pons Jaume89President &CSOSell20,000$11.15$223,036.00-3.1%-50.2%-95.4%
Mar 14, 2024Lettmann Jason70Chief Executive OfficerBuy4,400$11.31$49,771.48+2.6%-23.5%-92.6%
Jan 4, 2024Pinto Shelly76SVP, Finance And CAOSell2,717$13.60$36,956.63-3.3%-17.3%-86.1%